157 related articles for article (PubMed ID: 27026511)
1. Reply, Letter to the Editor - The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
Clin Nutr; 2016 Jun; 35(3):765-6. PubMed ID: 27026511
[No Abstract] [Full Text] [Related]
2. Re: The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Safer U; Binay Safer V
Clin Nutr; 2016 Jun; 35(3):764. PubMed ID: 27046044
[No Abstract] [Full Text] [Related]
3. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
[TBL] [Abstract][Full Text] [Related]
4. Multi-detector spiral CT diagnosis of common bile duct ampullary carcinoma.
Zhao DZ; Guo Y; Sun YP; Liu HM; Zhang Z; Ma QL; Wang YS; Chen CL
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3549-3553. PubMed ID: 28925490
[TBL] [Abstract][Full Text] [Related]
5. Computed tomography in the diagnosis and staging of cholangiocarcinoma and pancreatic carcinoma.
Freeny PC
Ann Oncol; 1999; 10 Suppl 4():12-7. PubMed ID: 10436776
[TBL] [Abstract][Full Text] [Related]
6. Reply to letter: "Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: the pitfalls of the study".
Farges O; Fuks D; Pruvot FR; Regimbeau JM
Ann Surg; 2014 Feb; 259(2):e37-8. PubMed ID: 23979284
[No Abstract] [Full Text] [Related]
7. Small pancreatic carcinoma misdiagnosed as superficially spreading cholangiocarcinoma.
Igami T; Yokoyama Y; Nishio H; Ebata T; Shimoyama Y; Nakamura S; Nagino M
J Hepatobiliary Pancreat Surg; 2009; 16(4):579-84. PubMed ID: 19259611
[TBL] [Abstract][Full Text] [Related]
8. Growing Evidence Supports the Use of Radiation Therapy in Unresectable Intrahepatic Cholangiocarcinoma.
Cuneo KC; Lawrence TS
Cancer J; 2016; 22(4):243-4. PubMed ID: 27441742
[No Abstract] [Full Text] [Related]
9. Liver transplantation for intrahepatic cholangiocarcinoma--Authors' reply.
Razumilava N; Gores GJ
Lancet; 2014 Sep; 384(9949):1182-3. PubMed ID: 25263671
[No Abstract] [Full Text] [Related]
10. Management and extent of resection for intrahepatic cholangiocarcinoma.
Carpizo DR; D'Angelica M
Surg Oncol Clin N Am; 2009 Apr; 18(2):289-305, viii-ix. PubMed ID: 19306813
[TBL] [Abstract][Full Text] [Related]
11. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
12. Histopathology of a benign bile duct lesion in the liver: Morphologic mimicker or precursor of intrahepatic cholangiocarcinoma.
Lee KB
Clin Mol Hepatol; 2016 Sep; 22(3):400-405. PubMed ID: 27729636
[TBL] [Abstract][Full Text] [Related]
13. Left hemihepatectomy and caudate lobectomy and complete extrahepatic bile duct resection using transduodenal approach for hilar cholangiocarcinoma arsing from biliary papillomatosis.
Kim JK; Hwang HK; Park JS; Cho SI; Yoon DS; Chi HS
J Surg Oncol; 2008 Aug; 98(2):139-42. PubMed ID: 18521837
[TBL] [Abstract][Full Text] [Related]
14. Discussion of: Is there a role for Ytrrium-90 in the treatment of unresectable and metastatic intrahepatic cholangiocarcinoma?
Am J Surg; 2018 Mar; 215(3):471. PubMed ID: 29502671
[No Abstract] [Full Text] [Related]
15. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
[TBL] [Abstract][Full Text] [Related]
16. Reply to "Radiologic Evaluation of Intrahepatic Cholangiocarcinoma Perineural Invasion".
Seo N; Kim DY; Choi JY
AJR Am J Roentgenol; 2018 Mar; 210(3):W130. PubMed ID: 29469626
[No Abstract] [Full Text] [Related]
17. Author's reply: To PMID 25003676.
Ince AT
Turk J Gastroenterol; 2014 Oct; 25(5):593. PubMed ID: 25566599
[No Abstract] [Full Text] [Related]
18. Transpapillary biliary biopsy for early stage cholangiocarcinoma of the distal common bile duct.
Asada M; Yazumi S; Yoshimoto T; Tamaki H; Matsuura M; Hasegawa K; Uenoyama Y; Hisatsune H; Nishio A; Chiba T
Gastrointest Endosc; 2006 Jul; 64(1):125-6; discussion 126. PubMed ID: 16813820
[No Abstract] [Full Text] [Related]
19. Oxaliplatin-eluting microspheres for the treatment of intrahepatic cholangiocarcinoma: a case report.
Poggi G; Quaretti P; Minoia C; Palumbo I; Villani L; Amatu A; Teragni C; Scelsi M; Zappoli F; Bernardo G
Anticancer Res; 2008; 28(5B):2987-90. PubMed ID: 19031944
[TBL] [Abstract][Full Text] [Related]
20. Pathologic classification of cholangiocarcinoma: New concepts.
Nakanuma Y; Kakuda Y
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):277-93. PubMed ID: 25966428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
